Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology

February 20, 2024 updated by: Peking University Third Hospital
The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics. The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint. The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China. The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery. On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Haidian
      • Beijing, Haidian, China
        • Recruiting
        • Peking University Third Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with lower limb defects

Description

Inclusion Criteria:

  1. Patients with traumatic lower limb bone defect;
  2. Infected lower limb bone defect patients;
  3. Patients with neoplastic lower limb bone defect;
  4. The above reasons caused bone defects of more than 5CM
  5. at least 18 years of age;
  6. Sign an informed agreement and join the study cohort voluntarily.

Exclusion Criteria:

  1. Patients who do not agree to the use of 3D printed microporous titanium alloy prostheses;
  2. Patients who cannot tolerate surgery;
  3. the subjects cannot comply with the follow-up or affect the scientific and integrity of the study;
  4. Other patients who were not suitable for inclusion as assessed by clinicians.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Traumatic bone defect in lower limb
3D printed prostheses
Infective lower limb bone defect
3D printed prostheses
Neoplastic bone defect in lower limb
3D printed prostheses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of implant stability, new bone growth- limb length
Time Frame: post-operative 1.3.6.12.24.36 months
X-ray X、CT images
post-operative 1.3.6.12.24.36 months
Evaluation of bone healing
Time Frame: post-operative 3.6.12.24.36 months
computed tomography (CT)
post-operative 3.6.12.24.36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessment
Time Frame: post-operative 1.3.6.12.24.36 months
Visual Analog Score (VAS), total score is 10, "0" represents no pain, "10" represents the most unbearable pain
post-operative 1.3.6.12.24.36 months
Evaluation of life quality and health status.
Time Frame: post-operative 1.3.6.12.24.36 months
36-item short form survery (SF-36) questionnaire, it includes 8 itmem, namely physical functioning, vitality, bodily pain, general health, social functioning, role physical, role emotional, mental health. The maximum score of each item is 100, higher score represents better result.
post-operative 1.3.6.12.24.36 months
Evaluation of knee function
Time Frame: post-operative 1.3.6.12.24.36 months
hospital for special surgery (HSS) score. The maximum score of HSS is 100, higher score represents better result.
post-operative 1.3.6.12.24.36 months
Evaluation of hip function
Time Frame: post-operative 1.3.6.12.24.36 months
Harris score, The maximum score of Harris score is 100, higher score represents better result.
post-operative 1.3.6.12.24.36 months
Evaluation of ankle function
Time Frame: post-operative 1.3.6.12.24.36 months
American Orthopaedic Foot & Ankle Society (AOFAS) score,The maximum score of AOFAS score is 100, higher score represents better result.
post-operative 1.3.6.12.24.36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

December 18, 2023

First Submitted That Met QC Criteria

February 20, 2024

First Posted (Estimated)

February 21, 2024

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 20231121-71479

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Defects

Clinical Trials on 3D printed prostheses

Subscribe